论文信息 - Long-term efficacy and safety of the intramyocardial implantation of autologous bone marrow cells for the treatment of ischemic heart disease. - 字舞流文

Long-term efficacy and safety of the intramyocardial implantation of autologous bone marrow cells for the treatment of ischemic heart disease.

Tao-Sheng Li | K. Hamano | A. Mikamo | Toshiro Kobayashi | B. Shirasawa | M. Murakami

[1] T. Asahara,et al. CD34-Positive Cells Exhibit Increased Potency and Safety for Therapeutic Neovascularization After Myocardial Infarction Compared With Total Mononuclear Cells , 2006, Circulation.

[2] A. Rosenzweig. Cardiac cell therapy--mixed results from mixed cells. , 2006, The New England journal of medicine.

[3] Tao-Sheng Li,et al. The Safety and Feasibility of the Local Implantation of Autologous Bone Marrow Cells for Ischemic Heart Disease , 2003, Journal of cardiac surgery.

[4] Catherine M. Verfaillie,et al. Pluripotency of mesenchymal stem cells derived from adult marrow , 2002, Nature.

[5] A. Kosaki,et al. Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and Cytokines , 2001, Circulation.